InflaRx N.V. (IFRX) Reports Positive Data form Third Cohort of Phase IIa Open-Label Study with Vilobelimab
Go back to InflaRx N.V. (IFRX) Reports Positive Data form Third Cohort of Phase IIa Open-Label Study with Vilobelimab| InferX Corporation (NASDAQ: IFRX) | Delayed: 1.93 +0.03 (1.58%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.90 | 52 Week High | $0.05 | |||
| Open | $1.84 | 52 Week Low | $0.00 | |||
| Day High | $1.98 | P/E | N/A | |||
| Day Low | $1.84 | EPS | $0.00 | |||
| Volume | 714,237 | |||||
